138 related articles for article (PubMed ID: 34896059)
1. Breast biopsy patterns and findings among older women undergoing screening mammography: The role of age and comorbidity.
Advani S; Abraham L; Buist DSM; Kerlikowske K; Miglioretti DL; Sprague BL; Henderson LM; Onega T; Schousboe JT; Demb J; Zhang D; Walter LC; Lee CI; Braithwaite D; O'Meara ES;
J Geriatr Oncol; 2022 Mar; 13(2):161-169. PubMed ID: 34896059
[TBL] [Abstract][Full Text] [Related]
2. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
[TBL] [Abstract][Full Text] [Related]
3. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.
Allison KH; Abraham LA; Weaver DL; Tosteson AN; Nelson HD; Onega T; Geller BM; Kerlikowske K; Carney PA; Ichikawa LE; Buist DS; Elmore JG
Cancer; 2015 May; 121(9):1369-78. PubMed ID: 25603785
[TBL] [Abstract][Full Text] [Related]
4. Comparison of screening mammography in the United States and the United kingdom.
Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
[TBL] [Abstract][Full Text] [Related]
5. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
[TBL] [Abstract][Full Text] [Related]
6. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
[TBL] [Abstract][Full Text] [Related]
7. Detection of ductal carcinoma in situ in women undergoing screening mammography.
Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
[TBL] [Abstract][Full Text] [Related]
8. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
Hendrick RE
Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
[TBL] [Abstract][Full Text] [Related]
9. Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.
Taplin SH; Abraham L; Geller BM; Yankaskas BC; Buist DS; Smith-Bindman R; Lehman C; Weaver D; Carney PA; Barlow WE
J Natl Cancer Inst; 2010 Jul; 102(14):1040-51. PubMed ID: 20601590
[TBL] [Abstract][Full Text] [Related]
10. Function-related Indicators and Outcomes of Screening Mammography in Older Women: Evidence from the Breast Cancer Surveillance Consortium Cohort.
Zhang D; Abraham L; Demb J; Miglioretti DL; Advani S; Sprague BL; Henderson LM; Onega T; Wernli KJ; Walter LC; Kerlikowske K; Schousboe JT; O'Meara ES; Braithwaite D;
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1582-1590. PubMed ID: 34078641
[TBL] [Abstract][Full Text] [Related]
11. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.
Fenton JJ; Xing G; Elmore JG; Bang H; Chen SL; Lindfors KK; Baldwin LM
Ann Intern Med; 2013 Apr; 158(8):580-7. PubMed ID: 23588746
[TBL] [Abstract][Full Text] [Related]
12. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
[TBL] [Abstract][Full Text] [Related]
13. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
Coldman A; Phillips N
CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
[TBL] [Abstract][Full Text] [Related]
14. Performance of digital screening mammography among older women in the United States.
Henderson LM; O'Meara ES; Braithwaite D; Onega T;
Cancer; 2015 May; 121(9):1379-86. PubMed ID: 25537958
[TBL] [Abstract][Full Text] [Related]
15. Detection Rates for Benign and Malignant Diagnoses on Breast Cancer Screening With Digital Breast Tomosynthesis in a Statewide Mammography Registry Study.
Fujii MH; Herschorn SD; Sowden M; Hotaling EL; Vacek PM; Weaver DL; Sprague BL
AJR Am J Roentgenol; 2019 Mar; 212(3):706-711. PubMed ID: 30673339
[TBL] [Abstract][Full Text] [Related]
16. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
17. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer detection with short-interval follow-up compared with return to annual screening in patients with benign stereotactic or US-guided breast biopsy results.
Johnson JM; Johnson AK; O'Meara ES; Miglioretti DL; Geller BM; Hotaling EN; Herschorn SD
Radiology; 2015 Apr; 275(1):54-60. PubMed ID: 25423143
[TBL] [Abstract][Full Text] [Related]
19. Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age.
Demb J; Abraham L; Miglioretti DL; Sprague BL; O'Meara ES; Advani S; Henderson LM; Onega T; Buist DSM; Schousboe JT; Walter LC; Kerlikowske K; Braithwaite D;
J Natl Cancer Inst; 2020 Jun; 112(6):599-606. PubMed ID: 31593591
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
